Metabolic syndrome in older HIV-infected patients: Data from the CORE50 cohort

AIDS Patient Care and STDs

Volumn 22, Issue 12, 2008, Pages 941-945

  Adeyemi, Oluwatoyin ^a   Rezai, Katayoun ^a   Bahk, Mieoak ^a   Badri, Sheila ^a   Thomas Gossain, Neena ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; ETHNIC GROUP; FEMALE; GERIATRIC CARE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PREVALENCE; SEX DIFFERENCE; SMOKING; WAIST CIRCUMFERENCE;

AGE FACTORS; AGED; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CHICAGO; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HIV INFECTIONS; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PREVALENCE; RISK FACTORS;

EID: 57449101866     PISSN: 10872914     EISSN: None     Source Type: Journal    
DOI: 10.1089/apc.2008.0119     Document Type: Article

References (18)

1. Carr A, Samras K, Burton S, et al. A syndrome of peripheral lipodystrophy, hyperlipidemia and insulin resistance in patients receiving HIV protease and insulin resistance in patients receiving HIV protease inhibitors. AIDS 1998;12:51-58.
2. Hadigan C, Meigs JB, Corcoran C, et al. metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy. Clin Infect Dis 2001;32:130-139.
3. Friss-Moller N, Weber R, Reiss P, et al. Cardiovascular disease risk factors in HIV patients: Association with antiretroviral therapy. Results from the DAD study. AIDS 2003;17:1179-1193.
4. Knobel H, Jerico C, Montero M, et al. Global cardiovascular risk in patients with HIV infection: concordance and differences in estimates according to three risk equations (Framingham, SCORE and PROCAM). AIDS PATIENT CARE and STDs 2007;452-461.
5. Mondy K, Overton ET, Grubb J, et al. Metabolic syndrome in HIV-infected patients from an urban, Midwestern US outpatient population. Clin Infect Dis 2007;44:726-734.
6. Jerico C, Knobel H, Montero M, et al. Metabolic syndrome among HIV-Infected patients; Prevalence, characteristics, and related factors. Diabetes Care 2005;28:144-149.
7. Palacios R, Santos J, Gonzalez M, et al. Incidence and prevalence of the metabolic syndrome in a cohort of naïve HIV infected patients: Prospective analysis at 48 weeks of highly active antiretroviral therapy. Int J STD AIDS 2007;18:184-187.
8. Ford ES, Gilles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: Findings from the third National Health and Nutrition Examination survey. JAMA 2002;287:356-359.
9. Grundy SM, Brewer HB, Cleeman JI, et al. Definition of the metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association. Conference on scientific issues related to definition. Circulation 2004;109:433-438.
10. Lakka HM, Laaksonen DE, Lakka TA, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002;288:2709-2716.
11. Ninomiya JK, L'Italien G, Criqui MH, et al. Association of the metabolic syndrome with history of myocardial infarction and stroke in the Third National Health and Nutrition Examination survey. Circulation 2004;109:42-46.
12. Isomaa B, Almgren P, Tuomi T, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001;24:683-689.
13. Wilson PWF, D'Agostino RB, Levy D, et al. Prediction of coronary heart disease using risk factor categories. Circulation 1998;97:1837-1847.
14. Dube MP, Stein J, Aberg J, et al. Guidelines for the evaluation and management of dyslipidemia in HIV-infected adults receiving antiretroviral therapy:recommendations of the HIV Medicine Association of the Infectious Disease Society of America and the Adult AIDS Clinical Trials Group. Clin Infect Dis 2003;37:613-627.
15. Kaplan RC, Kingsley LA, Sharrett AR, et al. Ten-year predicted coronary heart disease risk in HIV-infected men and women. Clin Infect Dis 2007;45:1074-1081.
16. Law MG, Friis Moller N, El-Sadr WM, et al. The use of the Framingham equation to predict myocardial infarctions in HIV-infected patients: Comparison with events observed in the DAD study. HIV Med 2006;7:218-230.
17. Gritz ER, Vidrine DJ, Lazev AB, et al. Smoking behavior in a low-income multiethnic HIV/AIDS population. Nicotine Tob Res 2004;6:71-77.
18. Glass TR, Ungsedhapand C, Wolbers M, et al. Prevalence of risk factors for cardiovascular disease in HIV-infected cardiovascular disease in HIV-infected patients over time: the Swiss HIV cohort Study. HIV Med 2006;7:404-410.